Seeing Is Believing
Currently out of the existing stock ratings of Tim Anderson, 15 are a BUY (27.78%), 31 are a HOLD (57.41%), 8 are a SELL (14.81%).
Analyst Tim Anderson, currently employed at BAML, carries an average stock price target met ratio of 76.54% that have a potential upside of 21.75% achieved within 288 days. Previously, Tim Anderson worked at WOLFE.
Tim Anderson’s has documented 117 price targets and ratings displayed on 12 stocks. The coverage is on Industrials, Healthcare sectors.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 17-Apr-2025.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 2/11/2025. The price target of $34 was fulfilled within 7 days with a profit of $3.07 (9.93%) receiving and performance score of 14.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$45
$12.7 (39.32%)
$50
22 days ago
(02-Apr-2025)
13/16 (81.25%)
$6.99 (18.39%)
57
Buy
$48
$15.7 (48.61%)
$55
29 days ago
(26-Mar-2025)
16/22 (72.73%)
$9.99 (26.28%)
240
Hold
$48
$15.7 (48.61%)
$49
3 months 14 days ago
(10-Jan-2025)
13/19 (68.42%)
$4.91 (11.39%)
161
Hold
$52
$19.7 (60.99%)
$45
4 months 14 days ago
(10-Dec-2024)
13/14 (92.86%)
$1.53 (3.03%)
178
Hold
$47
$14.7 (45.51%)
$41
5 months 19 days ago
(05-Nov-2024)
11/11 (100%)
$1.78 (3.94%)
323
Which stock is Tim Anderson is most bullish on?
Which stock is Tim Anderson is most reserved on?
What Year was the first public recommendation made by Tim Anderson?